Can a gleason 6 or less microfocus of prostate cancer in one biopsy and prostate-specific antigen level 10ng/ml be defined as the archetype of low-risk prostate disease?

Journal of Oncology

Volumn , Issue , 2012, Pages

  Taverna, Gianluigi ^a   Benecchi, Luigi ^b   Grizzi, Fabio ^a   Seveso, Mauro ^a   Giusti, Guido ^a   Piccinelli, Alessandro ^a   Benetti, Alessio ^a   Colombo, Piergiuseppe ^a   Minuti, Francesco ^a   Graziotti, Pierpaolo ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b Fidenza Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER RELAPSE; CANCER RISK; CANCER STAGING; DISEASE ASSOCIATION; GLEASON SCORE; HUMAN; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; MALE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; TUMOR VOLUME;

EID: 84864934716     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/645146     Document Type: Article

References (35)

1. Al Otaibi M., Ross P., Fahmy N., Jeyaganth S., Trottier H., Sircar K., Bégin L. R., Souhami L., Kassouf W., Aprikian A., Tanguay S., Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance Cancer 2008 113 2 286 292
2. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., Thun M. J., Cancer statistics, 2006 Ca-A Cancer Journal for Clinicians 2006 56 2 106 130
3. Rubin M. A., Targeted therapy of cancer: new roles for pathologistsprostate cancer Modern Pathology 2008 21 2 S44 S55
4. Holmberg L., Bill-Axelson A., Helgesen F., Salo J. O., Folmerz P., Hggman M., Andersson S. O., Spngberg A., Busch C., Nordling S., Palmgren J., Adami H. O., Johansson J. E., Norlén B. J., A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer The New England Journal of Medicine 2002 347 11 781 789 (Pubitemid 34988336)
5. Bill-Axelson A., Holmberg L., Ruutu M., Hggman M., Andersson S. O., Bratell S., Spngberg A., Busch C., Nordling S., Garmo H., Palmgren J., Adami H. O., Norlén B. J., Johansson J. E., Radical prostatectomy versus watchful waiting in early prostate cancer The New England Journal of Medicine 2005 352 19 1977 1984 (Pubitemid 40638368)
6. Andriole G. L., Crawford E. D., Grubb R. L. III, Buys S. S., Chia D., Church T. R., Fouad M. N., Gelmann E. P., Kvale P. A., Reding D. J., Weissfeld J. L., Yokochi L. A., O'Brien B., Clapp J. D., Rathmell J. M., Riley T. L., Hayes R. B., Kramer B. S., Izmirlian G., Miller A. B., Pinsky P. F., Prorok P. C., Gohagan J. K., Mortality results from a randomized prostate-cancer screening trial The New England Journal of Medicine 2009 360 13 1310 1319
7. Schrder F. H., Hugosson J., Roobol M. J., Tammela T. L. J., Ciatto S., Nelen V., Kwiatkowski M., Lujan M., Lilja H., Zappa M., Denis L. J., Recker F., Mpttnen A. B., Bangma C. H., Aus G., Villers A., Rebillard X., Van Kwast T. D., Blijenberg B. G., Moss S. M., De Koning H. J., Auvinen A., Screening and prostate-cancer mortality in a randomized european study The New England Journal of Medicine 2009 360 13 1320 1328
8. Catalona W., Smith D., Ratliff T., Basler J., Detection of organ-confined prostate cancer is increased through prostate- specific antigen-based screening JAMA 1993 270 8 948 954 (Pubitemid 23244733)
9. Bastian P. J., Carter B. H., Bjartell A., Seitz M., Stanislaus P., Montorsi F., Stief C. G., Schrder F., Insignificant prostate cancer and active surveillance: from definition to clinical implications European Urology 2009 55 6 1321 1330
10. Prostate cancer: diagnosis and treatment. Full Guideline developed for NICE by the National Collaborating Centre for Cancer. February 2008
11. Murthy V., Norman A. R., Shahidi M., Parker C. C., Horwich A., Huddart R. A., Bange A., Dearnaley D. P., Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer British Journal of Urology International 2006 97 3 476 479
12. Barry M. J., Screening for prostate cancerthe controversy that refuses to die The New England Journal of Medicine 2009 360 13 1351 1354
13. Chou R., Croswell J. M., Dana T., Screening for prostate cancer: a review of the evidence for the U.S. preventive services task force Annals of Internal Medicine 2011 155 11 762 771
14. Schrder F. H., Hugosson J., Roobol M. J., Tammela T. L. J., Ciatto S., Nelen V., Kwiatkowski M., Lujan M., Lilja H., Zappa M., Denis L. J., Recker F., Mpttnen A. B., Bangma C. H., Aus G., Villers A., Rebillard X., Van Kwast T. D., Blijenberg B. G., Moss S. M., De Koning H. J., Auvinen A., Prostate-cancer mortality at 11 years of follow-up The New England Journal of Medicine 2012 366 11 981 990
15. Epstein J. I., Walsh P. C., Carmichael M., Brendler C. B., Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 1994 271 5 368 374 (Pubitemid 24037911)
16. Stamey T. A., Freiha F. S., McNeal I. F., Redwine F. A., Whittemore A. S., Schmid H. P., Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer Cancer 1993 71 3 933 938 (Pubitemid 23049614)
17. Gardner T. A., Lemer M. L., Schlegel P. N., Waldbaum R. S., Vaughan E. D. Jr., Steckel J., Microfocal prostate cancer: biopsy cancer volume does not predict actual tumour volume British Journal of Urology 1998 81 6 839 843 (Pubitemid 28300613)
18. Terris M. K., McNeal J. F., Stamey T. A., Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies Journal of Urology 1992 148 3 I 829 832
19. Cupp M. R., Bostwick D. G., Myers R. P., Oesterling J. E., The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis Journal of Urology 1995 153 5 1543 1548
20. Taverna G., Colombo P., Seveso M., Giusti G., Piccinelli A., Benetti A., Graziotti P., Single small focus of prostate adenocarcinoma (≤ 1 mm and too small for grading) and clinical significant disease after radical prostatectomy Archivio Italiano di Urologia e Andrologia 2006 78 2 57 60
21. Thong A. E., Shikanov S., Katz M. H., Gofrit O. N., Eggener S., Zagaja G. P., Shalhav A. L., Zorn K. C., A single microfocus (5 or Less) of gleason 6 prostate cancer at biopsy-can we predict adverse pathological outcomes? Journal of Urology 2008 180 6 2436 2440
22. Allan R. W., Sanderson H., Epstein J. I., Correlation of minute (0.5 mm or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density Journal of Urology 2003 170 2 I 370 372 (Pubitemid 36870202)
23. Irwin M. B., Trapasso J. G., Identification of insignificant prostate cancers: analysis of preoperative parameters Urology 1994 44 6 862 867
24. Oon S. F., Watson R. W., O'Leary J. J., Fitzpatrick J. M., Epstein criteria for insignificant prostate cancer British Journal of Urology International 2011 108 4 518 525
25. Katz M. H., Shikanov S., Sun M., Abdollah F., Budaeus L., Gong E. M., Eggener S. E., Steinberg G. D., Zagaja G. P., Shalhav A. L., Karakiewicz P. I., Zorn K. C., Gleason 6 prostate cancer in one or two biopsy cores can harbor more aggressive disease Journal of Endourology 2011 25 4 699 703
26. Taverna G., Maffezzini M., Benetti A., Seveso M., Giusti G., Graziotti P., A single injection of lidocaine as local anesthesia for ultrasound guided needle biopsy of the prostate Journal of Urology 2002 167 1 222 223 (Pubitemid 34024537)
27. Egevad L., Norberg M., Mattson S., Norlén B. J., Busch C., Estimation of prostate cancer volume by multiple core biopsies before radical prostatectomy Urology 1998 52 4 653 658 (Pubitemid 28440175)
28. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M. J., Cancer statistics, 2008 CA Cancer Journal for Clinicians 2008 58 2 71 96 (Pubitemid 351521864)
29. Rubin M. A., Dunn R., Kambham N., Misick C. P., O'Toole K. M., Should a gleason score be assigned to a minute focus of carcinoma on prostate biopsy? American Journal of Surgical Pathology 2000 24 12 1634 1640
30. Franks L. M., Latent carcinoma of the prostate The Journal of Pathology and Bacteriology 1954 68 2 603 616
31. Etzioni R., Penson D. F., Legler J. M., Di Tommaso D., Boer R., Gann P. H., Feuer E. J., Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends Journal of the National Cancer Institute 2002 94 13 981 990 (Pubitemid 34814727)
32. Terris M. K., McNeal J. E., Stamey T. A., Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies Journal of Urology 1992 148 3 I 829 832
33. Cupp M. R., Bostwich D. G., Mayers R. P., Oesterling L. E., Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies Journal of Urology 1992 148 3 829 832
34. Sheridan T. B., Carter H. B., Wang W., Landis P. B., Epstein J. I., Change in prostate cancer grade over time in men followed expectantly for stage T1c disease Journal of Urology 2008 179 3 901 904
35. Ojea Calvo A., Gonzales Peneiro A., Dominguez Freire F., Alonso Rodrigo A., Rodriguez Iglesias B., Benavente Delgado J., Implicaciones pronosticas de los margenes positivos de la piezas de prostatectomia radical Actas Urolgicas Espaolas 2005 29 7 641 656